These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12593716)

  • 41. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells.
    McLachlan SM; Nagayama Y; Pichurin PN; Mizutori Y; Chen CR; Misharin A; Aliesky HA; Rapoport B
    Endocrinology; 2007 Dec; 148(12):5724-33. PubMed ID: 17823263
    [TBL] [Abstract][Full Text] [Related]  

  • 42. No prognostic value of thyroid autoantibodies changes during and after methimazole therapy in patients with Graves' disease.
    Lattanzi V; Ciampolillo A; Vincenti C; Giorgino R
    Boll Soc Ital Biol Sper; 1985 Apr; 61(4):507-13. PubMed ID: 3840026
    [No Abstract]   [Full Text] [Related]  

  • 43. Thyroid-stimulating autoantibodies usually contain only lambda-light chains: evidence for the "forbidden clone" theory.
    Knight J; Laing P; Knight A; Adams D; Ling N
    J Clin Endocrinol Metab; 1986 Feb; 62(2):342-7. PubMed ID: 2867105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The relationship between thyrotropin receptor antibody levels and intrathyroid vascularity in patients with Graves' disease.
    Shih SR; Chang JS; Lin LC; Chang YC; Li HY; Lee CY; Chen CM; Chang TC
    Exp Clin Endocrinol Diabetes; 2013 Jan; 121(1):1-5. PubMed ID: 23258570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation of microsomal antibodies with the intensity of the intrathyroidal autoimmune process in Graves' disease.
    Paschke R; Vogg M; Swillens S; Usadel KH
    J Clin Endocrinol Metab; 1993 Oct; 77(4):939-43. PubMed ID: 8408468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Microsomal antibodies].
    Kobayashi I
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():414-7. PubMed ID: 8753269
    [No Abstract]   [Full Text] [Related]  

  • 47. Long-term frozen sera for epidemiological studies of antibodies.
    Torfs CP; van der Berg BJ; Sever JL; Okerlund MD
    Lancet; 1986 Mar; 1(8479):503-4. PubMed ID: 2869240
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in schwannomas: the chosen clone matters.
    Creytens D; Van Bockstal M; Ferdinande L; Van Dorpe J
    Hum Pathol; 2018 Jun; 76():167-168. PubMed ID: 29634981
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in schwannomas: the chosen clone matters-reply.
    Wang DZ; Yao L; Tang XB
    Hum Pathol; 2018 Jun; 76():168-169. PubMed ID: 29634979
    [No Abstract]   [Full Text] [Related]  

  • 50. Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves' disease.
    Mizutori Y; Chen CR; Latrofa F; McLachlan SM; Rapoport B
    J Clin Endocrinol Metab; 2009 Mar; 94(3):927-35. PubMed ID: 19066298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autoimmunity of thyroid disease. With emphasis on Graves' disease.
    van Ouwerkerk BM; Krenning EP; Docter R; Benner R; Hennemann G
    Neth J Med; 1985; 28(1):32-9. PubMed ID: 2858065
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical relevance of immunological markers in Graves' disease.
    Mann K; Saller B; Hörmann R
    Exp Clin Endocrinol; 1991 May; 97(2-3):224-30. PubMed ID: 1680726
    [No Abstract]   [Full Text] [Related]  

  • 53. Monoclonal antibodies with thyroid stimulating activity, at last.
    Costagliola S; Vassart G
    Thyroid; 2002 Dec; 12(12):1039-41. PubMed ID: 12593716
    [No Abstract]   [Full Text] [Related]  

  • 54. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen.
    Baker JR; Saunders NB; Kaulfersch W; Burman KD
    J Immunol; 1988 Apr; 140(8):2593-9. PubMed ID: 2895790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thyroid-stimulating antibodies of Graves' disease in thyroid cancer.
    Röher HD; Goretzki PE; Frilling A
    N Engl J Med; 1988 Dec; 319(25):1669-70. PubMed ID: 3200284
    [No Abstract]   [Full Text] [Related]  

  • 56. Characterization of monoclonal antibodies derived from lymphocytes from Graves' disease patients in a cytochemical bioassay for thyroid stimulators.
    Ealey PA; Kohn LD; Ekins RP; Marshall NJ
    J Clin Endocrinol Metab; 1984 May; 58(5):909-14. PubMed ID: 6546765
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.